Financial

News

Stada revives talk of an IPO – if conditions improve

Germany's Stada has said it may make another attempt to seek a public listing in the autumn, after delaying its plans earlier this year.

News

CSL will slash headcount and hive off vaccine business

Facing declines in flu vaccination rates in the US, CSL will spin out its vaccine unit as part of a wider restructuring that will claim 3,000 jobs.

News

Iovance cuts staff on slower cell therapy sales growth

Iovance will slash 19% of its headcount in a restructuring that follows slower-than-expected sales growth for melanoma cell therapy Amtagvi.

News

Lilly weakens on oral weight-loss drug data

Shares in Eli Lilly have come under pressure after reporting the results of a phase 3 trial of oral weight-loss candidate orforglipron.

News

Bayer's job cull nears 12,000, with more to come

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – and isn't yet completed.

News

Novo Nordisk weakens again on interim results readout

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the first half of this year.

Stada revives talk of an IPO – if conditions improve

CSL will slash headcount and hive off vaccine business

Iovance cuts staff on slower cell therapy sales growth

Lilly weakens on oral weight-loss drug data

Bayer's job cull nears 12,000, with more to come

Novo Nordisk weakens again on interim results readout

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

Financial

Editor's Picks